Heart retransplant is a treatment option for some patients with graft failure. With heart donor short-age, it is important to assess candidates carefully for cardiac retransplant. An adult patient had a successful urgent heart retransplant due to severe toxic cardiomyopathy (anthracycline-induced) after posttransplant lymphoproliferative disease that was a diffuse large B-cell lymphoma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.6002/ect.2014.0077 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!